Your search matched 14 results
Climate change is named a top 10 health threat and we’ve broken down the conundrum for pharma companies regarding activating on the issue.
You think you’re busy?
The Week That Was: ... | Blog
Our favorite #healthpolicyvalentines, new FDA guidance regarding complex generics and what you need to know now regarding data security from pharma and patient perspectives.
What do vacationers on a cruise ship in St.
It’s seems like it’s being marketed as a treatment for everything from pain to anxiety, but is it legal?
SCOTUS is weighing its options on a number of healthcare cases; using social activism to tip the scales for your brand reputation; and crowdfunding for what?
Winter is coming… in May.
Policymakers continue their focus on drug pricing and may also have eyes for changes to the Orphan Drug Act.
As drug pricing continues to be under the microscope, it’s a tough environment for drug makers.
This week's edition of The Week That Was details how health and medical groups are taking action to address the “greatest public health challenge of the 21st century” and what you need to know from a busy week in healthcare policy.
Missed BIO 2019?
80% of voters support importing drugs from Canada and politicians on both sides of the aisle agree.
“Timing is everything - particularly when lives are at stake.”